Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population

INTRODUCTION: Due to the vaccine’s short supply and the efficacy of a single dose of the ChAdOx1 (AZD1222) vaccine, many governments delayed the interval between prime and boost dose from 4 to 8–12 weeks. However, the waning of immune response in this period is a concern. This study evaluated the du...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawinprai, Kriangkrai, Siripongboonsitti, Taweegrit, Porntharukchareon, Thachanun, Dechates, Bothamai, Monprach, Harnphadungkit, Sornsamdang, Gaidganok, Wittayasak, Kasiruck, Soonklang, Kamonwan, Mahanonda, Nithi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935462/
https://www.ncbi.nlm.nih.gov/pubmed/35240945
http://dx.doi.org/10.1080/21645515.2022.2035573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935462/
https://www.ncbi.nlm.nih.gov/pubmed/35240945
http://dx.doi.org/10.1080/21645515.2022.2035573

Ejemplares similares